Symbol: |
WDR16
|
Description: |
WD repeat domain 16 [Source:HGNC Symbol;Acc:16053]
|
Location: |
Chr17:9479944-9546776[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:108
Gene |
Compound |
Gen_sig |
Exp_pattern |
WDR16 |
NSC 41274 |
0.036 |
Up |
WDR16 |
Neocuproin |
0.013 |
Down |
WDR16 |
C.I. 37559 |
0.025 |
Up |
WDR16 |
NSC 58903 |
0.005 |
Up |
WDR16 |
Camptothecin hemisuccinate sodium salt |
0.034 |
Up |
WDR16 |
4-Morpholinepentanoic acid, .alpha.-(phenylmethylene)- .beta.-oxo-, ethyl ester, hydrochloride |
0.012 |
Up |
WDR16 |
Oxalic acid, mono(4,9-dihydro-4,9-dioxonaphtho[2,3-d] thiazol-2-yl)hydrazide, monoethyl ester |
0.018 |
Up |
WDR16 |
Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(3-methoxy- phenyl)methylene]-, hydrochloride |
0.02 |
Up |
WDR16 |
3,8,13,18-Pentaazapentacosane pentahydrochloride |
0.002 |
Down |
WDR16 |
NSC 641594 |
0.04 |
Up |
WDR16 |
Pyrimidine, 2-[1,5-bis(4-chlorophenyl)-1H-1,2,3-triazol-4-yl]- 1,4,5,6-tetrahydro- |
0.018 |
Down |
WDR16 |
3-Furancarbothioamide, [[3-(2-butenoxy)-4-methoxyphenyl]- 2-methyl- |
0.028 |
Up |
WDR16 |
ANTINEOPLASTIC-654379 |
0.042 |
Up |
WDR16 |
NSC 656471 |
0.033 |
Down |
WDR16 |
NSC 65683 |
0.036 |
Down |
Expression pattern: Sensitivity / Resistance
Total:8 Current:2
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:7
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:57
Total:4 Current:1
[First] [Prev]  Next Last 
|